Emmanuel Donnadieu

20PUBLICATIONS
84CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|May 28, 2025
Systemic delivery of cadherin 17-specific CAR T cells allows effective and safe targeting of colorectal cancer liver metastases.

|Nov 27, 2024
Subverting Attachment to Prevent Attacking: Alteration of Effector Immune Cell Migration and Adhesion as a Key Mechanism of Tumor Immune Evasion.

Marta Mastrogiovanni, Emmanuel Donnadieu, Rajiv Pathak

|Oct 09, 2024
Targeting the MAtrix REgulating MOtif abolishes several hallmarks of cancer, triggering antitumor immunity.

Chengbei Li, Amanpreet Kaur, Alexia Pavlidaki

|Mar 12, 2024
Mitochondrial metabolism sustains CD8+ T cell migration for an efficient infiltration into solid tumors.

Luca Simula, Mattia Fumagalli, Lene Vimeux

|Jun 28, 2023
The RHOA Mutation G17V Does Not Lead to Increased Migration of Human Malignant T Cells but Is Associated with Matrix Remodelling.

Katrin Merk-Ahmad, Julia Bein, Sonja Scharf

|Jun 08, 2023
ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma.

Nadia Mensali, Hakan Köksal, Sandy Joaquina

Pageof 4

Frequent Collaborators

3 joint publications

Sonja Scharf

3 joint publications

Sylvia Hartmann

3 joint publications

Luca Simula

2 joint publications

Lene Vimeux